Expression of the p53 gene was also evaluated in all breast cancer subtypes, i.e., luminal A, luminal B, HER2-positive, TNBC, and basal-like, and the findings suggested that p53 had a higher expression within HER2-positive and TNBC subtypes than in luminal A and luminal B subtypes. The gene discussed is ERBB2; the disease is breast cancer.